The study describes the results of Octreoscan SPET evaluation in patients (14) with recurrent aggressive fibromatosis, a rare therapy-resistant connective pathology. Spet study was performed; the imaging provides acquisition at 4 and 24 hours after the injection. There were a qualitative and quantitative approaches.
Octreoscan results in aggressive fibromatosis: Diagnostic ( extension disease ) and new therapetic approaches, values.
CAPANNA, RODOLFO
2000-01-01
Abstract
The study describes the results of Octreoscan SPET evaluation in patients (14) with recurrent aggressive fibromatosis, a rare therapy-resistant connective pathology. Spet study was performed; the imaging provides acquisition at 4 and 24 hours after the injection. There were a qualitative and quantitative approaches.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
